Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Efficacy of ceftazidime-avibactam in a rat intra-abdominal abscess model against a ceftazidime- and meropenem-resistant isolate of Klebsiella pneumoniae carrying blaKPC-2.

Sleger T, Gangl E, Pop-Damkov P, Krause KM, Laud PJ, Slee AM, Nichols WW.

J Chemother. 2018 Apr;30(2):95-100. doi: 10.1080/1120009X.2017.1405609. Epub 2017 Nov 30.

2.

Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens.

Grossman TH, Fyfe C, O'Brien W, Hackel M, Minyard MB, Waites KB, Dubois J, Murphy TM, Slee AM, Weiss WJ, Sutcliffe JA.

mSphere. 2017 Feb 22;2(1). pii: e00004-17. doi: 10.1128/mSphere.00004-17. eCollection 2017 Jan-Feb.

3.

Eravacycline (TP-434) is efficacious in animal models of infection.

Grossman TH, Murphy TM, Slee AM, Lofland D, Sutcliffe JA.

Antimicrob Agents Chemother. 2015 May;59(5):2567-71. doi: 10.1128/AAC.04354-14. Epub 2015 Feb 17.

4.

Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis.

Shoen CM, DeStefano MS, Sklaney MR, Monica BJ, Slee AM, Cynamon MH.

J Antimicrob Chemother. 2004 Apr;53(4):641-5. Epub 2004 Feb 18.

PMID:
14973154
5.

Alpha(v)beta(3) integrin in angiogenesis and restenosis.

Kerr JS, Mousa SA, Slee AM.

Drug News Perspect. 2001 Apr;14(3):143-50.

PMID:
12819820
6.

The alpha v integrin antagonists as novel anticancer agents: an update.

Kerr JS, Slee AM, Mousa SA.

Expert Opin Investig Drugs. 2002 Dec;11(12):1765-74. Review.

PMID:
12457436
7.

The hollow fiber assay.

Hall LA, Krauthauser CM, Wexler RS, Slee AM, Kerr JS.

Methods Mol Med. 2003;74:545-66. No abstract available.

PMID:
12415720
8.

Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.

Sizemore CF, Quispe JD, Amsler KM, Modzelewski TC, Merrill JJ, Stevenson DA, Foster LA, Slee AM.

Antimicrob Agents Chemother. 2002 May;46(5):1435-40.

9.

An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat.

Wexler EJ, Peters EE, Gonzales A, Gonzales ML, Slee AM, Kerr JS.

J Neurosci Methods. 2002 Jan 15;113(1):51-8.

PMID:
11741721
10.

Oxazolidinones mechanism of action: inhibition of the first peptide bond formation.

Patel U, Yan YP, Hobbs FW Jr, Kaczmarczyk J, Slee AM, Pompliano DL, Kurilla MG, Bobkova EV.

J Biol Chem. 2001 Oct 5;276(40):37199-205. Epub 2001 Aug 1.

11.

Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assay.

Krauthauser CM, Hall LA, Wexler RS, Slee AM, Mitra J, Enders GH, Kerr JS.

Anticancer Res. 2001 Mar-Apr;21(2A):869-72.

PMID:
11396177
12.

Small molecule alpha(v) integrin antagonists: novel anticancer agents.

Kerr JS, Slee AM, Mousa SA.

Expert Opin Investig Drugs. 2000 Jun;9(6):1271-9. Review.

PMID:
11060742
13.

Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis.

Wong PC, Crain EJ, Knabb RM, Meade RP, Quan ML, Watson CA, Wexler RR, Wright MR, Slee AM.

J Pharmacol Exp Ther. 2000 Oct;295(1):212-8.

PMID:
10991981
14.

Tumor biology: use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatments.

Wexler EJ, Gravallese EM, Czerniak PM, Devenny JJ, Longtine J, Wong MK, Slee AM, Kerr JS.

Clin Cancer Res. 2000 Aug;6(8):3361-70.

15.

The hollow fiber assay: continued characterization with novel approaches.

Hall LA, Krauthauser CM, Wexler RS, Hollingshead MG, Slee AM, Kerr JS.

Anticancer Res. 2000 Mar-Apr;20(2A):903-11.

PMID:
10810375
16.

Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors.

Kerr JS, Wexler RS, Mousa SA, Robinson CS, Wexler EJ, Mohamed S, Voss ME, Devenny JJ, Czerniak PM, Gudzelak A Jr, Slee AM.

Anticancer Res. 1999 Mar-Apr;19(2A):959-68.

PMID:
10368639
17.

Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.

Mousa SA, Bozarth JM, Lorelli W, Forsythe MS, Thoolen MJ, Slee AM, Reilly TM, Friedman PA.

J Pharmacol Exp Ther. 1998 Sep;286(3):1277-84.

PMID:
9732389
18.

Antibacterials. synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives.

Park CH, Brittelli DR, Wang CL, Marsh FD, Gregory WA, Wuonola MA, McRipley RJ, Eberly VS, Slee AM, Forbes M.

J Med Chem. 1992 Mar 20;35(6):1156-65.

PMID:
1552508
19.

An automated pulse labelling method for structure-activity relationship studies with antibacterial oxazolidinones.

Eustice DC, Brittelli DR, Feldman PA, Brown LJ, Borkowski JJ, Slee AM.

Drugs Exp Clin Res. 1990;16(4):149-55.

PMID:
2127566
20.

Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group.

Gregory WA, Brittelli DR, Wang CL, Wuonola MA, McRipley RJ, Eustice DC, Eberly VS, Bartholomew PT, Slee AM, Forbes M.

J Med Chem. 1989 Aug;32(8):1673-81.

PMID:
2502627
21.

The in vitro dental plaque inhibitory properties of a series of N-[1-alkyl-4(1H)-pyridinylidene]alkylamines.

Wentland MP, Bailey DM, Powles RG, Slee AM, Sedlock DM.

J Med Chem. 1988 Oct;31(10):2024-7.

PMID:
3172139
22.

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis.

Eustice DC, Feldman PA, Zajac I, Slee AM.

Antimicrob Agents Chemother. 1988 Aug;32(8):1218-22.

23.

The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis.

Eustice DC, Feldman PA, Slee AM.

Biochem Biophys Res Commun. 1988 Feb 15;150(3):965-71.

PMID:
2449210
24.

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721.

Slee AM, Wuonola MA, McRipley RJ, Zajac I, Zawada MJ, Bartholomew PT, Gregory WA, Forbes M.

Antimicrob Agents Chemother. 1987 Nov;31(11):1791-7.

25.

The effect of daily treatments with an octenidine dentifrice formulation on gingival health in cynomolgus monkeys.

Slee AM, Cimijotti E, Rothstein S.

J Periodontal Res. 1985 Sep;20(5):542-9. No abstract available.

PMID:
2934539
26.

Bispyridinamines: a new class of topical antimicrobial agents as inhibitors of dental plaque.

Bailey DM, DeGrazia CG, Hoff SJ, Schulenberg PL, O'Connor JR, Paris DA, Slee AM.

J Med Chem. 1984 Nov;27(11):1457-64.

PMID:
6492075
27.

Relationship between structure and antiplaque and antimicrobial activities for a series of bispyridines.

Slee AM, O'Connor JR, Bailey DM.

Antimicrob Agents Chemother. 1983 Apr;23(4):531-5.

29.

Saccharin inhibits tooth decay in laboratory models.

Tanzer JM, Slee AM.

J Am Dent Assoc. 1983 Mar;106(3):331-3. No abstract available.

PMID:
6573411
31.

Sucrose transport by Streptococcus mutans. Evidence for multiple transport systems.

Slee AM, Tanzer JM.

Biochim Biophys Acta. 1982 Nov 22;692(3):415-24.

PMID:
7171603
32.

Predominant microflora associated with human dental periapical abscesses.

Oguntebi B, Slee AM, Tanzer JM, Langeland K.

J Clin Microbiol. 1982 May;15(5):964-66.

33.
35.
36.

Studies on the relative binding affinities of chlorhexidine analogs to cation exchange surfaces.

Slee AM, Tanzer JM.

J Periodontal Res. 1979 May;14(3):213-9. No abstract available.

PMID:
158080
37.

In vitro evaluation of seven cationic detergents as antiplaque agents.

Tanzer JM, Slee AM, Kamay B, Scheer ER.

Antimicrob Agents Chemother. 1979 Mar;15(3):408-14.

38.
39.

Activity of three 8-hydroxyquinoline derivatives against in vitro dental plaque.

Tanzer JM, Slee AM, Kamay B, Scheer E.

Antimicrob Agents Chemother. 1978 Jun;13(6):1044-5.

40.

Structural requirements of guanide, biguanide, and bisbiguanide agents for antiplaque activity.

Tanzer JM, Slee AM, Kamay BA.

Antimicrob Agents Chemother. 1977 Dec;12(6):721-9.

41.

In vitro evaluation of three iodine-containing compounds as antiplaque agents.

Tanzer JM, Slee AM, Kamay B, Scheer ER.

Antimicrob Agents Chemother. 1977 Jul;12(1):107-13.

Supplemental Content

Support Center